FDA Warning Letter — Cannafyl

Case 611957 — FEI 3015928484

The FDA took a Warning Letter action against Cannafyl on Mar 1, 2021 (Phoenix, AZ). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Cannafyl
Date
Mar 1, 2021
Fiscal Year
2021
Product Type
Drugs
Center
CDER
Location
Phoenix, AZ (United States)